Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: J Mol Cell Cardiol. 2009 Nov 13;48(2):367. doi: 10.1016/j.yjmcc.2009.11.003

Fig. 1.

Fig. 1

Median lethal dose (LD50) and lysosomal membrane stability in FVB and MT mice treated with or without LPS. A: Various dosages of LPS-induced mortality in mice over a period of 72 hrs. LD50 was calculated using the probit analysis method; B: Lysosomal membrane stability evaluated by the lysosomal enzyme β-glucuronidase activity in FVB and MT mice treated with or without LPS (4 mg/kg, i.p.) for 4 hrs. Mean ± SEM, n = 30 mice in each strain for panel A; n = 6–7 per group for panel B, p value provided in panel A exhibited significant difference between the two.